A Warp-Knitted Light-Emitting Fabric-Based Device for In Vitro Photodynamic Therapy: Description, Characterization, and Application on Human Cancer Cell Lines

被引:5
|
作者
Thecua, Elise [1 ,2 ]
Ziane, Laurine [1 ]
Grolez, Guillaume Paul [1 ]
Fagart, Alexandre [1 ,3 ]
Kumar, Abhishek [1 ]
Leroux, Bertrand [1 ]
Baert, Gregory [1 ]
Deleporte, Pascal [1 ]
Vermandel, Maximilien [1 ]
Vignion-Dewalle, Anne-Sophie [1 ]
Delhem, Nadira [1 ]
Mordon, Serge [1 ]
机构
[1] Univ Lille, INSERM, CHU Lille, U1189 ONCO THAI Laser Assisted Therapy & Immunoth, F-59000 Lille, France
[2] MDB TEXINOV, F-38110 St Didier De La Tour, France
[3] CHU Lille, Dept Nucl Med, F-59000 Lille, France
关键词
photodynamic therapy; light-emitting fabric; in vitro device; optics; optical fibers; laser; LED; 5-AMINOLEVULINIC ACID; FLUENCE RATE; ACTINIC KERATOSES; CARCINOMA; TEMPERATURE; PERFORMANCE; EFFICACY; DELIVERY; DESIGN; LOSSES;
D O I
10.3390/cancers13164109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary While photodynamic therapy appears to be a promising approach to treating cancers, the complexity of its parameters prevents wide acceptance. Accurate light dose measurement is one of the keys to photodynamic effect assessment, but it remains challenging when comparing different technologies. This work provides a complete demonstration of the technical performance of a homemade optical device, based on knitted light-emitting fabrics, called CELL-LEF. Thermal and optical distributions and related safeties are investigated. The results are discussed in relation to the requirements of photodynamic therapy. The usability of CELL-LEF is investigated on human cancer cell lines as a proof of concept. This study highlights that new light-emitting fabric-based technologies can be relevant light sources for in vitro photodynamic therapy studies of tomorrow. Photodynamic therapy (PDT) appears to be a promising strategy in biomedical applications. However, the complexity of its parameters prevents wide acceptance. This work presents and characterizes a novel optical device based on knitted light-emitting fabrics and dedicated to in vitro PDT involving low irradiance over a long illumination period. Technical characterization of this device, called CELL-LEF, is performed. A cytotoxic study of 5-ALA-mediated PDT on human cancer cell lines is provided as a proof of concept. The target of delivering an irradiance of 1 mW/cm(2) over 750 cm(2) is achieved (mean: 0.99 mW/cm(2); standard deviation: 0.13 mW/cm(2)). The device can maintain a stable temperature with the mean thermal distribution of 35.1 degrees C (min: 30.7 degrees C; max: 38.4 degrees C). In vitro outcomes show that 5-ALA PDT using CELL-LEF consistently and effectively induced a decrease in tumor cell viability: Almost all the HepG2 cells died after 80 min of illumination, while less than 60% of U87 cell viability remained. CELL-LEF is suitable for in vitro PDT involving low irradiance over a long illumination period.
引用
收藏
页数:19
相关论文
共 2 条
  • [1] A New Light-Emitting, Fabric-Based Device for Photodynamic Therapy of Actinic Keratosis: Protocol for a Randomized, Controlled, Multicenter, Intra-Individual, Phase II Noninferiority Study (the Phosistos Study)
    Vignion-Dewalle, Anne-Sophie
    Rached, Henry Abi
    Thecua, Elise
    Lecomte, Fabienne
    Deleporte, Pascal
    Behal, Helene
    Hommel, Theresa
    Duhamel, Alain
    Szeimies, Rolf-Markus
    Mortier, Laurent
    Mordon, Serge
    JMIR RESEARCH PROTOCOLS, 2019, 8 (04):
  • [2] Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight protocol) compared with the conventional protocol involving irradiation with the Aktilite CL 128 lamp
    Vicentini, C.
    Vignion-Dewalle, A. S.
    Thecua, E.
    Lecomte, F.
    Maire, C.
    Deleporte, P.
    Behal, H.
    Kerob, D.
    Duhamel, A.
    Mordon, S.
    Mortier, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (04) : 765 - 773